Dr. Reddy's Laboratories Limited (DRREDDY.NS)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic
1,390.20 INR-0.76%As of 2026-11-22 · INR
Last session low 1,384.80 INRLast session high 1,400.00 INR
52-week low 1,101.00 INR52-week high 1,414.90 INR
Market cap (USD)
$12.51B
Sector
Healthcare
P/E (TTM)
41.4x
Dividend yield
0.58%
Next earnings
2027-01-21 (est.)

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in INR.

IndicatorValueReading
RSI (14)69.0In the neutral range (30 to 70)
MACD (12, 26, 9)38.66Below its signal line (40.54); histogram -1.88
Bollinger %B (20, 2)70%Inside the bands (1,280.96 to 1,437.73)
SMA 201,359.35Price is 2.3% above
SMA 501,264.51Price is 9.9% above
SMA 2001,253.57Price is 10.9% above
ATR (20)1.77% of priceAverage true range per day
52-week position92%In the upper part of the 1,101.00 to 1,414.90 range

About Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment.

Latest fiscal yearEnded 2026-03-31: revenue of 335.93B INR and an operating margin of 14.9%.
Next earnings reportExpected on 2027-01-21 (the date is an estimate).

Also listed as RDY (NYSE)

More in Drug Manufacturers - Specialty & Generic